×

SOLUBLE ErbB3 AND TREATMENT OF CANCER

  • US 20080267961A1
  • Filed: 06/23/2008
  • Published: 10/30/2008
  • Est. Priority Date: 05/31/2001
  • Status: Active Grant
First Claim
Patent Images

1. A method for regulating heregulin activity, said method comprising administering an effective amount of an sErbB3 agent.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×